E-mail

E-mail a Wiley Online Library Link

Rune Nilsson, Linda Mårtensson, Sophie E. Eriksson, Hans-Olov Sjögren and Jan Tennvall Toxicity-reducing potential of extracorporeal affinity adsorption treatment in combination with the auristatin-conjugated monoclonal antibody BR96 in a syngeneic rat tumor model Cancer 116

Version of Record online: 2 FEB 2010 | DOI: 10.1002/cncr.24790

Extracorporeal affinity adsorption treatment can be used to reduce the toxicity associated with administration of monomethylauristatin FBR96 conjugates, making it possible to increase the amount of conjugates administered.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH